Zinbryta Interactions
There are 456 drugs known to interact with Zinbryta (daclizumab), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 48 are major, 400 are moderate, and 8 are minor.
- View all 456 medications that may interact with Zinbryta
- View Zinbryta alcohol/food interactions (1)
- View Zinbryta disease interactions (5)
Most frequently checked interactions
View interaction reports for Zinbryta (daclizumab) and the medicines listed below.
- acyclovir
- Amrix (cyclobenzaprine)
- baclofen
- Carafate (sucralfate)
- Cymbalta (duloxetine)
- Depakote (divalproex sodium)
- doxepin
- Fioricet (acetaminophen / butalbital / caffeine)
- gabapentin
- Imbruvica (ibrutinib)
- Inderal (propranolol)
- levothyroxine
- Linzess (linaclotide)
- lisinopril
- megestrol
- modafinil
- Neupro (rotigotine)
- Norco (acetaminophen / hydrocodone)
- Norvir (ritonavir)
- Ocrevus (ocrelizumab)
- Prilosec (omeprazole)
- Synthroid (levothyroxine)
- tizanidine
- tramadol
- Tylenol (acetaminophen)
- Venclexta (venetoclax)
- VESIcare (solifenacin)
- Viibryd (vilazodone)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
Zinbryta alcohol/food interactions
There is 1 alcohol/food interaction with Zinbryta (daclizumab).
Zinbryta disease interactions
There are 5 disease interactions with Zinbryta (daclizumab) which include:
Report options
QR code containing a link to this page
More about Zinbryta (daclizumab)
- Zinbryta consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.